Clinical Trial

A Trial of Itraconazole Effect on HRS-8080 Pharmacokinetics in Healthy Participants

Completed Phase 1
View on ClinicalTrials.gov →
Summary
This is a phase I study to evaluate the effect of Itraconazole on the pharmacokinetics of HRS-8080 in healthy participants and the safety of HRS-8080 administered alone and in combination with Itraconazole in healthy participants.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-13; most recent amendment 2026-01-13.
Status change: Active, Not Recruiting → Completed 2026-01-13
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-12-09
Trial Details
NCT Number NCT07229560
Lead Sponsor Shandong Suncadia Medicine Co., Ltd.
Conditions Breast Cancer
Enrollment 16 participants
Start Date 2025-11-26
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-14